Update on investigation into possible problems with hypodermic needles
The Dutch National Institute for Public Health and the Environment (RIVM) is currently investigating possible problems with hypodermic needles manufactured by the manufacturer Terumo. RIVM was asked to conduct this investigation by the Dutch Health Care Inspectorate (IGZ).
RIVM has now received a large number of samples of hypodermic needles from Terumo’s factory in Belgium and from distributors and various Dutch hospitals. Needles produced by other manufacturers will also be investigated. In addition, the investigation will draw on information provided by the ‘whistleblower’ and the results of inspection visits to the Terumo factory. These visits will be conducted by IGZ in concert with the Belgian and German authorities.
The RIVM investigation is likely to take several weeks. If the investigation reveals any risk to patient safety, IGZ will of course take immediate and appropriate action. Pending the results of the investigation, IGZ advises the use of alternative hypodermic needles, if available, rather than those supplied by Terumo (Terumo K-Pack II and Neolus). This is a precautionary measure at this stage.